Oskar joined BGV as a partner at the start of the third fund in July 2016. Oskar currently serves on the board of SurgVision, VarmX and Mellon Medical.
Prior to joining BGV Oskar worked in McKinsey & Company as a management consultant. Subsequently he held various business development and commercial roles in Crucell and Johnson&Johnson (after acquiring Crucell). More recently he was the chief commercial officer at Avantium.
Oskar has a degree in chemical engineering from Twente University and holds a MBA from INSEAD.
MSc Chemical Engineering
McKinsey&Company, Crucell, Johnson&Johnson, Avantium